Knight Therapeutics | GUD - Umlaufvermögen

Aktienkurs
7.51
Täglich Wechseln
0.06 0.81%
Monatlich
1.35%
Jährlich
22.51%
Q2 Prognose
7.39




Umlaufvermögen Veränderung Datum
Acasti Pharma USD 17.3M 3.22M 2025-09
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Canopy Growth CAD 524.67M 78.85M 2025-12
Cronos Group USD 944.09M 21.94M 2025-12
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
IQVIA Holdings USD 6.25B 270M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Moderna USD 6.54B 54M 2025-12
Omeros USD 69.65M 26.53M 2025-06
Organigram Holdings CAD 256.54M 28.35M 2025-12
Organon & Co USD 4.35B 348M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 9.79B 162.2M 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12